Chemoinformaics analysis of 29-Nor-20-oxolupeol
Molecular Weight | 428.701 | nRot | 1 |
Heavy Atom Molecular Weight | 380.317 | nRig | 26 |
Exact Molecular Weight | 428.365 | nRing | 5 |
Solubility: LogS | -5.292 | nHRing | 0 |
Solubility: LogP | 6.128 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 82.0401 |
nHD | 1 | BPOL | 49.0219 |
QED | 0.486 |
Synth | 4.646 |
Natural Product Likeliness | 2.909 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.321 |
Pgp-sub | 0 |
HIA | 0.011 |
CACO-2 | -5.027 |
MDCK | 0.00000996 |
BBB | 0.928 |
PPB | 0.991859 |
VDSS | 1.453 |
FU | 0.0204751 |
CYP1A2-inh | 0.02 |
CYP1A2-sub | 0.638 |
CYP2c19-inh | 0.055 |
CYP2c19-sub | 0.966 |
CYP2c9-inh | 0.088 |
CYP2c9-sub | 0.405 |
CYP2d6-inh | 0.021 |
CYP2d6-sub | 0.86 |
CYP3a4-inh | 0.132 |
CYP3a4-sub | 0.603 |
CL | 22.968 |
T12 | 0.027 |
hERG | 0.021 |
Ames | 0.01 |
ROA | 0.389 |
SkinSen | 0.562 |
Carcinogencity | 0.008 |
EI | 0.095 |
Respiratory | 0.962 |
NR-Aromatase | 0.382 |
Antiviral | No |
Prediction | 0.675039 |